| UniProt ID | 6PGD_HUMAN | |
|---|---|---|
| UniProt AC | P52209 | |
| Protein Name | 6-phosphogluconate dehydrogenase, decarboxylating | |
| Gene Name | PGD | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 483 | |
| Subcellular Localization | Cytoplasm. | |
| Protein Description | Catalyzes the oxidative decarboxylation of 6-phosphogluconate to ribulose 5-phosphate and CO(2), with concomitant reduction of NADP to NADPH.. | |
| Protein Sequence | MAQADIALIGLAVMGQNLILNMNDHGFVVCAFNRTVSKVDDFLANEAKGTKVVGAQSLKEMVSKLKKPRRIILLVKAGQAVDDFIEKLVPLLDTGDIIIDGGNSEYRDTTRRCRDLKAKGILFVGSGVSGGEEGARYGPSLMPGGNKEAWPHIKTIFQGIAAKVGTGEPCCDWVGDEGAGHFVKMVHNGIEYGDMQLICEAYHLMKDVLGMAQDEMAQAFEDWNKTELDSFLIEITANILKFQDTDGKHLLPKIRDSAGQKGTGKWTAISALEYGVPVTLIGEAVFARCLSSLKDERIQASKKLKGPQKFQFDGDKKSFLEDIRKALYASKIISYAQGFMLLRQAATEFGWTLNYGGIALMWRGGCIIRSVFLGKIKDAFDRNPELQNLLLDDFFKSAVENCQDSWRRAVSTGVQAGIPMPCFTTALSFYDGYRHEMLPASLIQAQRDYFGAHTYELLAKPGQFIHTNWTGHGGTVSSSSYNA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 25 | Acetylation | LILNMNDHGFVVCAF EEEECCCCCEEEEEE | 26.96 | - | |
| 25 | Ubiquitination | LILNMNDHGFVVCAF EEEECCCCCEEEEEE | 26.96 | - | |
| 25 | Acetylation | LILNMNDHGFVVCAF EEEECCCCCEEEEEE | 26.96 | 19608861 | |
| 25 | Ubiquitination | LILNMNDHGFVVCAF EEEECCCCCEEEEEE | 26.96 | 19608861 | |
| 35 | Ubiquitination | VVCAFNRTVSKVDDF EEEEEECCCCCHHHH | 30.18 | - | |
| 35 | Phosphorylation | VVCAFNRTVSKVDDF EEEEEECCCCCHHHH | 30.18 | 28450419 | |
| 37 | Phosphorylation | CAFNRTVSKVDDFLA EEEECCCCCHHHHHH | 26.75 | 29978859 | |
| 38 | Ubiquitination | AFNRTVSKVDDFLAN EEECCCCCHHHHHHH | 45.40 | 21890473 | |
| 38 | Ubiquitination | AFNRTVSKVDDFLAN EEECCCCCHHHHHHH | 45.40 | 21890473 | |
| 38 | Acetylation | AFNRTVSKVDDFLAN EEECCCCCHHHHHHH | 45.40 | 23954790 | |
| 38 | Malonylation | AFNRTVSKVDDFLAN EEECCCCCHHHHHHH | 45.40 | 26320211 | |
| 38 | Ubiquitination | AFNRTVSKVDDFLAN EEECCCCCHHHHHHH | 45.40 | 21890473 | |
| 46 | Acetylation | VDDFLANEAKGTKVV HHHHHHHCCCCCCEE | 46.26 | - | |
| 46 | Ubiquitination | VDDFLANEAKGTKVV HHHHHHHCCCCCCEE | 46.26 | - | |
| 46 | Acetylation | VDDFLANEAKGTKVV HHHHHHHCCCCCCEE | 46.26 | 19608861 | |
| 46 | Ubiquitination | VDDFLANEAKGTKVV HHHHHHHCCCCCCEE | 46.26 | 19608861 | |
| 48 | 2-Hydroxyisobutyrylation | DFLANEAKGTKVVGA HHHHHCCCCCCEECC | 62.02 | - | |
| 48 | Malonylation | DFLANEAKGTKVVGA HHHHHCCCCCCEECC | 62.02 | 26320211 | |
| 48 | Ubiquitination | DFLANEAKGTKVVGA HHHHHCCCCCCEECC | 62.02 | 21906983 | |
| 50 | Phosphorylation | LANEAKGTKVVGAQS HHHCCCCCCEECCHH | 21.69 | 22210691 | |
| 51 | Malonylation | ANEAKGTKVVGAQSL HHCCCCCCEECCHHH | 43.52 | 32601280 | |
| 51 | Ubiquitination | ANEAKGTKVVGAQSL HHCCCCCCEECCHHH | 43.52 | - | |
| 57 | Phosphorylation | TKVVGAQSLKEMVSK CCEECCHHHHHHHHH | 40.66 | 22210691 | |
| 59 | Ubiquitination | VVGAQSLKEMVSKLK EECCHHHHHHHHHCC | 49.35 | 21890473 | |
| 59 | Ubiquitination | VVGAQSLKEMVSKLK EECCHHHHHHHHHCC | 49.35 | 21890473 | |
| 59 | 2-Hydroxyisobutyrylation | VVGAQSLKEMVSKLK EECCHHHHHHHHHCC | 49.35 | - | |
| 59 | Acetylation | VVGAQSLKEMVSKLK EECCHHHHHHHHHCC | 49.35 | 19608861 | |
| 59 | Malonylation | VVGAQSLKEMVSKLK EECCHHHHHHHHHCC | 49.35 | 26320211 | |
| 59 | Ubiquitination | VVGAQSLKEMVSKLK EECCHHHHHHHHHCC | 49.35 | 21890473 | |
| 63 | Acetylation | QSLKEMVSKLKKPRR HHHHHHHHHCCCCCE | 30.84 | 19608861 | |
| 74 | Acetylation | KPRRIILLVKAGQAV CCCEEEEEEECCHHH | 2.33 | - | |
| 76 | 2-Hydroxyisobutyrylation | RRIILLVKAGQAVDD CEEEEEEECCHHHHH | 46.93 | - | |
| 76 | Acetylation | RRIILLVKAGQAVDD CEEEEEEECCHHHHH | 46.93 | 19608861 | |
| 87 | Acetylation | AVDDFIEKLVPLLDT HHHHHHHHHHHHHCC | 50.39 | 21466224 | |
| 94 | Phosphorylation | KLVPLLDTGDIIIDG HHHHHHCCCCEEEEC | 36.40 | 24076635 | |
| 104 | Phosphorylation | IIIDGGNSEYRDTTR EEEECCCHHHCCCCH | 39.00 | 21712546 | |
| 106 | Ubiquitination | IDGGNSEYRDTTRRC EECCCHHHCCCCHHH | 17.38 | - | |
| 106 | Phosphorylation | IDGGNSEYRDTTRRC EECCCHHHCCCCHHH | 17.38 | - | |
| 119 | Ubiquitination | RCRDLKAKGILFVGS HHHHHCCCCEEEEEC | 44.92 | 21890473 | |
| 119 | Ubiquitination | RCRDLKAKGILFVGS HHHHHCCCCEEEEEC | 44.92 | 21890473 | |
| 119 | 2-Hydroxyisobutyrylation | RCRDLKAKGILFVGS HHHHHCCCCEEEEEC | 44.92 | - | |
| 119 | Ubiquitination | RCRDLKAKGILFVGS HHHHHCCCCEEEEEC | 44.92 | 21906983 | |
| 126 | Phosphorylation | KGILFVGSGVSGGEE CCEEEEECCCCCCCC | 30.62 | 23403867 | |
| 129 | Phosphorylation | LFVGSGVSGGEEGAR EEEECCCCCCCCCCC | 44.60 | 25159151 | |
| 134 | Ubiquitination | GVSGGEEGARYGPSL CCCCCCCCCCCCCCC | 15.85 | - | |
| 141 | Acetylation | GARYGPSLMPGGNKE CCCCCCCCCCCCCCC | 5.59 | - | |
| 141 | Ubiquitination | GARYGPSLMPGGNKE CCCCCCCCCCCCCCC | 5.59 | - | |
| 141 | Acetylation | GARYGPSLMPGGNKE CCCCCCCCCCCCCCC | 5.59 | 19608861 | |
| 141 | Ubiquitination | GARYGPSLMPGGNKE CCCCCCCCCCCCCCC | 5.59 | 19608861 | |
| 142 | Sulfoxidation | ARYGPSLMPGGNKEA CCCCCCCCCCCCCCC | 3.21 | 30846556 | |
| 147 | Acetylation | SLMPGGNKEAWPHIK CCCCCCCCCCCHHHH | 52.67 | 7430939 | |
| 147 | Ubiquitination | SLMPGGNKEAWPHIK CCCCCCCCCCCHHHH | 52.67 | - | |
| 150 | Ubiquitination | PGGNKEAWPHIKTIF CCCCCCCCHHHHHHH | 6.01 | - | |
| 154 | Ubiquitination | KEAWPHIKTIFQGIA CCCCHHHHHHHHHHH | 32.31 | 21890473 | |
| 154 | Ubiquitination | KEAWPHIKTIFQGIA CCCCHHHHHHHHHHH | 32.31 | 21890473 | |
| 154 | Acetylation | KEAWPHIKTIFQGIA CCCCHHHHHHHHHHH | 32.31 | 23236377 | |
| 154 | Ubiquitination | KEAWPHIKTIFQGIA CCCCHHHHHHHHHHH | 32.31 | 21890473 | |
| 163 | Acetylation | IFQGIAAKVGTGEPC HHHHHHHHHCCCCCC | 31.98 | 25953088 | |
| 163 | Ubiquitination | IFQGIAAKVGTGEPC HHHHHHHHHCCCCCC | 31.98 | - | |
| 166 | Phosphorylation | GIAAKVGTGEPCCDW HHHHHHCCCCCCCCC | 41.16 | 25159151 | |
| 184 | Ubiquitination | EGAGHFVKMVHNGIE CCCHHHHHCCCCCCC | 33.97 | - | |
| 235 | Ubiquitination | LDSFLIEITANILKF HHHHHHHHHHHHHHE | 3.32 | - | |
| 248 | 2-Hydroxyisobutyrylation | KFQDTDGKHLLPKIR HEECCCCCCCCHHHH | 33.61 | - | |
| 248 | Acetylation | KFQDTDGKHLLPKIR HEECCCCCCCCHHHH | 33.61 | 25825284 | |
| 248 | Ubiquitination | KFQDTDGKHLLPKIR HEECCCCCCCCHHHH | 33.61 | - | |
| 252 | Ubiquitination | TDGKHLLPKIRDSAG CCCCCCCHHHHCCCC | 36.07 | - | |
| 253 | 2-Hydroxyisobutyrylation | DGKHLLPKIRDSAGQ CCCCCCHHHHCCCCC | 50.79 | - | |
| 253 | Ubiquitination | DGKHLLPKIRDSAGQ CCCCCCHHHHCCCCC | 50.79 | - | |
| 257 | Phosphorylation | LLPKIRDSAGQKGTG CCHHHHCCCCCCCCC | 25.17 | 24719451 | |
| 261 | Ubiquitination | IRDSAGQKGTGKWTA HHCCCCCCCCCCCHH | 58.48 | - | |
| 263 | Phosphorylation | DSAGQKGTGKWTAIS CCCCCCCCCCCHHHH | 42.49 | 18785766 | |
| 265 | Ubiquitination | AGQKGTGKWTAISAL CCCCCCCCCHHHHHH | 41.01 | - | |
| 281 | Ubiquitination | YGVPVTLIGEAVFAR HCCCEEEEHHHHHHH | 3.24 | - | |
| 291 | Phosphorylation | AVFARCLSSLKDERI HHHHHHHHCCCHHHH | 36.93 | 24719451 | |
| 292 | Phosphorylation | VFARCLSSLKDERIQ HHHHHHHCCCHHHHH | 26.87 | 24719451 | |
| 294 | Acetylation | ARCLSSLKDERIQAS HHHHHCCCHHHHHHH | 60.53 | 25953088 | |
| 294 | Ubiquitination | ARCLSSLKDERIQAS HHHHHCCCHHHHHHH | 60.53 | - | |
| 296 | Acetylation | CLSSLKDERIQASKK HHHCCCHHHHHHHHH | 50.53 | - | |
| 296 | Acetylation | CLSSLKDERIQASKK HHHCCCHHHHHHHHH | 50.53 | 19608861 | |
| 303 | Acetylation | ERIQASKKLKGPQKF HHHHHHHHCCCCCCC | 53.59 | - | |
| 303 | Ubiquitination | ERIQASKKLKGPQKF HHHHHHHHCCCCCCC | 53.59 | - | |
| 304 | Ubiquitination | RIQASKKLKGPQKFQ HHHHHHHCCCCCCCC | 9.97 | - | |
| 309 | 2-Hydroxyisobutyrylation | KKLKGPQKFQFDGDK HHCCCCCCCCCCCCH | 44.24 | - | |
| 309 | Acetylation | KKLKGPQKFQFDGDK HHCCCCCCCCCCCCH | 44.24 | 19608861 | |
| 309 | Ubiquitination | KKLKGPQKFQFDGDK HHCCCCCCCCCCCCH | 44.24 | 19608861 | |
| 316 | 2-Hydroxyisobutyrylation | KFQFDGDKKSFLEDI CCCCCCCHHHHHHHH | 56.71 | - | |
| 316 | Acetylation | KFQFDGDKKSFLEDI CCCCCCCHHHHHHHH | 56.71 | 23749302 | |
| 316 | Ubiquitination | KFQFDGDKKSFLEDI CCCCCCCHHHHHHHH | 56.71 | - | |
| 317 | 2-Hydroxyisobutyrylation | FQFDGDKKSFLEDIR CCCCCCHHHHHHHHH | 51.70 | - | |
| 317 | Acetylation | FQFDGDKKSFLEDIR CCCCCCHHHHHHHHH | 51.70 | 26822725 | |
| 317 | Ubiquitination | FQFDGDKKSFLEDIR CCCCCCHHHHHHHHH | 51.70 | - | |
| 318 | Phosphorylation | QFDGDKKSFLEDIRK CCCCCHHHHHHHHHH | 40.58 | 27050516 | |
| 324 | Methylation | KSFLEDIRKALYASK HHHHHHHHHHHHHHH | 30.43 | 115487209 | |
| 325 | 2-Hydroxyisobutyrylation | SFLEDIRKALYASKI HHHHHHHHHHHHHHH | 42.98 | - | |
| 334 | Phosphorylation | LYASKIISYAQGFML HHHHHHHHHHHHHHH | 20.21 | 23917254 | |
| 335 | Phosphorylation | YASKIISYAQGFMLL HHHHHHHHHHHHHHH | 7.79 | 23917254 | |
| 340 | Sulfoxidation | ISYAQGFMLLRQAAT HHHHHHHHHHHHHHH | 4.39 | 30846556 | |
| 364 | Ubiquitination | GIALMWRGGCIIRSV CEEEEEECCEEHHHH | 21.58 | - | |
| 375 | Acetylation | IRSVFLGKIKDAFDR HHHHHHHHHHHHHHC | 49.05 | 25953088 | |
| 377 | 2-Hydroxyisobutyrylation | SVFLGKIKDAFDRNP HHHHHHHHHHHHCCH | 46.63 | - | |
| 377 | Ubiquitination | SVFLGKIKDAFDRNP HHHHHHHHHHHHCCH | 46.63 | 21906983 | |
| 447 | Ubiquitination | ASLIQAQRDYFGAHT HHHHHHHHHHHCCCH | 43.54 | - | |
| 449 | Phosphorylation | LIQAQRDYFGAHTYE HHHHHHHHHCCCHHH | 13.20 | 28152594 | |
| 454 | Phosphorylation | RDYFGAHTYELLAKP HHHHCCCHHHHHCCC | 20.39 | 28796482 | |
| 455 | Phosphorylation | DYFGAHTYELLAKPG HHHCCCHHHHHCCCC | 8.50 | 28796482 | |
| 460 | Ubiquitination | HTYELLAKPGQFIHT CHHHHHCCCCCEEEC | 50.04 | - | |
| 467 | Phosphorylation | KPGQFIHTNWTGHGG CCCCEEECCCCCCCC | 27.86 | 29514088 | |
| 470 | Phosphorylation | QFIHTNWTGHGGTVS CEEECCCCCCCCCCC | 22.75 | 20068231 | |
| 475 | Phosphorylation | NWTGHGGTVSSSSYN CCCCCCCCCCCCCCC | 23.08 | 28450419 | |
| 477 | Phosphorylation | TGHGGTVSSSSYNA- CCCCCCCCCCCCCC- | 25.08 | 28796482 | |
| 478 | Phosphorylation | GHGGTVSSSSYNA-- CCCCCCCCCCCCC-- | 20.97 | 28796482 | |
| 479 | Phosphorylation | HGGTVSSSSYNA--- CCCCCCCCCCCC--- | 29.36 | 28796482 | |
| 480 | Phosphorylation | GGTVSSSSYNA---- CCCCCCCCCCC---- | 25.10 | 28464451 | |
| 481 | Phosphorylation | GTVSSSSYNA----- CCCCCCCCCC----- | 19.63 | 28796482 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 481 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of 6PGD_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of 6PGD_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| AL7A1_HUMAN | ALDH7A1 | physical | 22863883 | |
| AL9A1_HUMAN | ALDH9A1 | physical | 22863883 | |
| EF2_HUMAN | EEF2 | physical | 22863883 | |
| AGAL_HUMAN | GLA | physical | 22863883 | |
| GNAI3_HUMAN | GNAI3 | physical | 22863883 | |
| HMGB2_HUMAN | HMGB2 | physical | 22863883 | |
| KS6A1_HUMAN | RPS6KA1 | physical | 22863883 | |
| TXND5_HUMAN | TXNDC5 | physical | 22863883 | |
| FABP5_HUMAN | FABP5 | physical | 26344197 | |
| GDIA_HUMAN | GDI1 | physical | 26344197 | |
| PDIA1_HUMAN | P4HB | physical | 26344197 | |
| SUMO3_HUMAN | SUMO3 | physical | 26344197 | |
| TALDO_HUMAN | TALDO1 | physical | 26344197 |
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| There are no disease associations of PTM sites. | |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB00851 | Dacarbazine |
| DB00695 | Furosemide |
| DB00789 | Gadopentetate dimeglumine |
| DB00920 | Ketotifen |
| DB00814 | Meloxicam |
| DB00563 | Methotrexate |
| DB00867 | Ritodrine |
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-38; LYS-59; LYS-76; LYS-154AND LYS-309, AND MASS SPECTROMETRY. | |